Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)

SHA:600267 Revenue

Zhejiang Hisun Pharmaceutical had revenue of 2.39B CNY in the quarter ending March 31, 2026, a decrease of -9.17%. This brings the company's revenue in the last twelve months to 10.31B, up 6.36% year-over-year. In the year 2025, Zhejiang Hisun Pharmaceutical had annual revenue of 10.55B with 2.03% growth.

• Revenue (ttm): 10.31B
• Revenue Growth: +6.36%
• P/S Ratio: 1.22
• Revenue / Employee: 1.18M
• Employees: 8,751
• Market Cap: 12.61B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.55B	209.39M	2.03%
Dec 31, 2024	10.34B	-32.82M	-0.32%
Dec 31, 2023	10.37B	-1.66B	-13.82%
Dec 31, 2022	12.04B	-99.78M	-0.82%
Dec 31, 2021	12.14B	782.07M	6.89%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error